ArticleFrontiers in surgery2025
Ultrasound- guided microwave ablation for symptomatic breast cysts: early outcomes and clinical implications.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cysts are more common in premenopausal women (61.5%), particularly between ages 35-50. Microwave ablation (MWA) has shown advantages in treating symptomatic cysts. Objective: To evaluate early outcomes of ultrasound-guided MWA for breast cysts at the Breast Unit of Cho Ray Hospital. Methods: A retrospective review was conducted on patients who underwent MWA from August 2018 to March 2020. Results: Fifty-eight patients (mean age: 45.3) were included. Simple, complicated, and complex cysts accounted for 80.0%, 16.9%, and 3.1%, respectively. The mean cyst diameter was 23.86 mm. A size reduction exceeding 90% was observed in the ablated cyst at the 6 months follow- up, with the exception of 1 cyst with mural calcification that showed no response. Conclusion: MWA is a promising and safe treatment for symptomatic breast cysts, offering high success and low complication rates. Cyst mural calcification may affect treatment response and should be carefully assessed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.